Fri, May 24, 2013, 12:40 PM EDT - U.S. Markets close in 3 hrs 20 mins
Copaxone still seems to be the preferred treatment for MS. And may be a money maker generic for MNTA down the road.
just in case you missed the article: http://news.yahoo.com/fda-warns-seizures-ms-drug-ampyra-161501758--finance.html